Information Journal Paper
APA:
Copy. (2020). ADMA (asymmetric dimethylarginine) and angiogenic potential in patients with type 2 diabetes and prediabetes. EXPERIMENTAL BIOLOGY AND MEDICINE (MAYWOOD, N.J.), -(-), 0-0. SID. https://sid.ir/paper/671220/en
Vancouver:
Copy. ADMA (asymmetric dimethylarginine) and angiogenic potential in patients with type 2 diabetes and prediabetes. EXPERIMENTAL BIOLOGY AND MEDICINE (MAYWOOD, N.J.)[Internet]. 2020;-(-):0-0. Available from: https://sid.ir/paper/671220/en
IEEE:
Copy, “ADMA (asymmetric dimethylarginine) and angiogenic potential in patients with type 2 diabetes and prediabetes,” EXPERIMENTAL BIOLOGY AND MEDICINE (MAYWOOD, N.J.), vol. -, no. -, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/671220/en